6-K 1 ea144327-6k_scisparcltd.htm REPORT OF FOREIGN PRIVATE ISSUER

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of July 2021 (Report No. 2)

 

Commission file number: 001- 38041

 

SCISPARC LTD.

(Translation of registrant’s name into English)

 

20 Raul Wallenberg Street, Tower A,

Tel Aviv 6971916 Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F         Form 40-F 

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1):_____

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7):_____

 

 

 

 

 

 

CONTENTS

 

On July 16, 2021, SciSparc Ltd. (the “Company”) convened its Special General Meeting of Shareholders (the “Special Meeting”); however, it was adjourned for three days to the same time and place due to lack of quorum. Accordingly, the Company’s adjourned Special Meeting will be convened on Monday, July 19, 2021, at 8:00 a.m. (Eastern Time) / 3:00 p.m. (Israel time) and will be held at the Company’s offices, 20 Raul Wallenberg Street, Tower A Tel Aviv 6971916 Israel (the “Adjourned Special Meeting”). If a quorum is not present within half an hour, any number of shareholders who are present in person or proxy, or who have delivered a proxy card, will constitute a quorum, and shall be entitled to deliberate and to resolve in respect of the matter for which the Special Meeting was convened. Proxy cards delivered for the Special Meeting will be voted at the Adjourned Special Meeting.

 

This Report on Form 6-K is incorporated by reference into the registration statements on Form F-3 (File No. 333-225745 and File No. 333-233417) and on Form S-8 (File No. 333-225773) of the Company, filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  

  SciSparc Ltd.
   
Date: July 16, 2021 By: /s/ Oz Adler
    Name:  Oz Adler
    Title: Chief Financial Officer

 

 

2